(20S)-Protopanaxatriol

CAS No. 34080-08-5

(20S)-Protopanaxatriol ( 20(S)-APPT; g-PPT )

Catalog No. M18440 CAS No. 34080-08-5

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 In Stock
10MG 71 In Stock
50MG 235 In Stock
100MG 376 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (20S)-Protopanaxatriol
  • Note
    Research use only, not for human use.
  • Brief Description
    (20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.
  • Description
    (20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.
  • Synonyms
    20(S)-APPT; g-PPT
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    34080-08-5
  • Formula Weight
    476.73
  • Molecular Formula
    C30H52O4
  • Purity
    98%
  • Solubility
    DMSO : ≥ 47 mg/mL;98.59 mM
  • SMILES
    C1C[C@@H](C([C@@H]2[C@H](C[C@]3([C@@]4(CC[C@@H]([C@H]4[C@@H](C[C@@H]3[C@@]12C)O)[C@](C)(CCC=C(C)C)O)C)C)O)(C)C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang Y, et al. Sci Rep. 2014 Dec 9;4:7375.
molnova catalog
related products
  • Nanaomycin A

    Nanaomycin A, a quinone antibiotics, reactivates silenced tumor suppressor genes in human cancer cells. Nanaomycin A is a selective inhibitor of DNMT3B (IC50 = 500 nM).

  • Osalmid

    Osalmid is a choleretic drug.

  • Fialuridine

    Fialuridine is a DNA-directed DNA polymerase inhibitor potentially for the treatment of HBV infection with potent activity against hepatitis B virus in vitro and in vivo.